Dhitavat S, Rivera E R, Rogers E, Shea T B
Department of Biological Sciences, University of Massachusetts Lowell, Lowell MA 01854, USA.
J Alzheimers Dis. 2001 Jan 1;3(6):525-9.
Exposure of neurons to amyloid-beta (Abeta) is accompanied by a cascade of oxidative damage that initiates with lipid peroxidation followed by subsequent generation of cytosolic free radicals and reactive oxygen species (ROS). The antioxidant vitamin E has been utilized to counteract Abeta-induced oxidative stress. We considered herein whether or not the lipid-solubility of vitamin E limits its neuroprotection to membrane-related oxidative damage, and renders it relatively ineffective where prior lipid peroxidation has already generated cytosolic free radicals and ROS. To test this possibility, we treated differentiated SH-SY-5Y human neuroblastoma with vitamin E or a cell-permeant antioxidant, N-acetyl cysteine (NAC), simultaneously with or 15 min after the application of Abeta. Both vitamin E and NAC prevented Abeta-induced ROS generation when applied simultaneously with Abeta, but only NAC prevented Abeta-induced ROS generation when added to cultures that had previously been exposed to Abeta. These results support the hypothesis that vitamin E can quench Abeta-induced lipid peroxidation, but cannot effectively quench ROS generated by prior lipid peroxidation. These findings in cell culture may provide limited insight into why vitamin E is not fully effective against neurodegeneration in AD in clinical settings, since some neuronal populations are likely to already have been compromised by prior Abeta exposure before vitamin E treatment was initiated.
神经元暴露于β-淀粉样蛋白(Aβ)时会伴随着一系列氧化损伤,这种损伤始于脂质过氧化,随后是胞质自由基和活性氧(ROS)的产生。抗氧化剂维生素E已被用于对抗Aβ诱导的氧化应激。我们在此考虑维生素E的脂溶性是否限制了其对膜相关氧化损伤的神经保护作用,以及在先前的脂质过氧化已经产生胞质自由基和ROS的情况下,它是否相对无效。为了检验这种可能性,我们在应用Aβ的同时或之后15分钟,用维生素E或一种细胞渗透性抗氧化剂N-乙酰半胱氨酸(NAC)处理分化的SH-SY-5Y人神经母细胞瘤。当与Aβ同时应用时,维生素E和NAC都能阻止Aβ诱导的ROS产生,但当添加到先前已暴露于Aβ的培养物中时,只有NAC能阻止Aβ诱导的ROS产生。这些结果支持了这样的假设,即维生素E可以淬灭Aβ诱导的脂质过氧化,但不能有效地淬灭先前脂质过氧化产生的ROS。细胞培养中的这些发现可能为维生素E在临床环境中对阿尔茨海默病(AD)的神经退行性变不完全有效的原因提供有限的见解,因为在开始维生素E治疗之前,一些神经元群体可能已经因先前暴露于Aβ而受到损害。